In a research report issued today, Alpha BioPharma’s Paul Nunzio DeSantis initiated coverage on shares of GlobeImmune (NASDAQ:GBIM) with a Buy rating and $17 price target, which represents …
In a research report released today, Alpha BioPharma’s Paul Nunzio DeSantis initiated coverage on shares of Achillion Pharmaceuticals (NASDAQ:ACHN) with a Buy rating and $16 price …
